4.7 Article

Global patterns in testicular cancer incidence and mortality in 2020

期刊

INTERNATIONAL JOURNAL OF CANCER
卷 151, 期 5, 页码 692-698

出版社

WILEY
DOI: 10.1002/ijc.33999

关键词

incidence; mortality; testicular cancer

类别

向作者/读者索取更多资源

Testicular cancer is the most common cancer in young men of European ancestry and has been increasing in incidence, although mortality rates have been declining in high-income settings. Globally, testicular cancer is the most common cancer in men aged 15 to 44, with the highest incidence rates in Western, Northern, and Southern Europe and Oceania, and the lowest rates in Asia and Africa. Mortality rates are highest in Central and South America, and lowest in Northern Europe, Northern Africa, and Eastern Asia. There is significant variation in incidence and mortality rates among different countries.
With 74 500 new cases worldwide in 2020, testicular cancer ranks as the 20th leading cancer type, but is the most common cancer in young men of European ancestry. While testicular cancer incidence has been rising in many populations, mortality trends, at least those in high-income settings, have been in decline since the 1970s following the introduction of platinum-based chemotherapy. To examine current incidence and mortality patterns, we extracted the new cases of, and deaths from cancers of the testis from the GLOBOCAN 2020 database. In 2020, testicular cancer was the most common cancer in men aged 15 to 44 in 62 countries worldwide. Incidence rates were highest in West-, North- and South-Europe and Oceania (age-standardised rate, ASR >= 7/100 000), followed by North America (5.6/100 000 and lowest (<2/100 000) in Asia and Africa. The mortality rates were highest in Central and South America (0.84 and 0.54 per 100 000, respectively), followed by Eastern and Southern Europe, and Western and Southern Africa. The lowest mortality rates were in Northern Europe, Northern Africa and Eastern Asia (0.16, 0.14, 0.9 per 100 000, respectively). At the country level, incidence rates varied over 100-fold, from 10/100 000 in Norway, Slovenia, Denmark and Germany to <= 0.10/100 000 in Gambia, Guinea, Liberia, Lesotho. Mortality rates were highest in Fiji, Argentina and Mexico. Our results indicate a higher mortality burden in countries undergoing economic transitions and reinforce the need for more equitable access to testicular cancer diagnosis and treatment globally.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据